CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Private Placement	Registered Direct Offering	Common stock	Common stock Private Placement	Common stock Registered Direct Offering	Additional paid in capital	Additional paid in capital Private Placement	Additional paid in capital Registered Direct Offering	Treasury stock	Accumulated deficit	Accumulated other comprehensive loss
Beginning balance, common shares (in shares) at Dec. 31, 2022				127,022,363
Beginning balance at Dec. 31, 2022	$ (37,872)			$ 14			$ 272,528			$ (57,350)	$ (253,064)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(39,110)										(39,110)
Foreign currency translation	0
Equity-based compensation expense	12,592						12,592
Issuance of Private Placement shares/Registered Direct Offering shares (in shares)					13,888,889	11,848,341
Issuance of Private Placement shares/Registered Direct Offering shares		$ 7,081	$ 6,765		$ 2	$ 1		$ 7,079	$ 6,764
Issuance of shares for equity-based compensation awards, net (in shares)				2,585,688
Issuance of shares for equity-based compensation awards, net	(2,276)						(2,276)
Issuance of shares for exercised convertible notes (in shares)				188
Issuance of shares purchased under ESPP (in shares)				708,470
Issuance of shares purchased under ESPP	531						531
Ending balance, common shares (in shares) at Sep. 30, 2023				156,053,939
Ending balance at Sep. 30, 2023	(52,289)			$ 17			297,218			(57,350)	(292,174)	0
Beginning balance, common shares (in shares) at Jun. 30, 2023				155,452,774
Beginning balance at Jun. 30, 2023	(61,573)			$ 17			291,933			(57,350)	(296,173)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	3,999										3,999
Foreign currency translation	0
Equity-based compensation expense	4,793						4,793
Issuance of shares for equity-based compensation awards, net (in shares)				601,165
Issuance of shares for equity-based compensation awards, net	(39)						(39)
Issuance of shares purchased under ESPP	531						531
Ending balance, common shares (in shares) at Sep. 30, 2023				156,053,939
Ending balance at Sep. 30, 2023	$ (52,289)			$ 17			297,218			(57,350)	(292,174)	0
Beginning balance, common shares (in shares) at Dec. 31, 2023	157,287,522			157,287,522
Beginning balance at Dec. 31, 2023	$ (67,335)			$ 17			303,428			(57,350)	(313,430)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(149,060)										(149,060)
Foreign currency translation	(8)											(8)
Equity-based compensation expense	$ 16,074						16,074
Exercise of options (in shares)	87,324			87,324
Exercise of options	$ 119						119
Issuance of common shares as consideration for the acquisition of Pangiam (in shares)				63,982,145
Issuance of common shares as consideration for the acquisition of Pangiam	210,763			$ 6			210,757
Exercise of warrants (in shares)				22,775,144
Exercise of warrants	90,707			$ 2			90,705
Issuance of shares for equity-based compensation awards, net (in shares)				5,454,373
Issuance of shares for equity-based compensation awards, net	(3,434)						(3,434)
Issuance of shares for exercised convertible notes (in shares)				94
Issuance of shares purchased under ESPP (in shares)				474,325
Issuance of shares purchased under ESPP	$ 607						607
Ending balance, common shares (in shares) at Sep. 30, 2024	250,060,927			250,060,927
Ending balance at Sep. 30, 2024	$ 98,433			$ 25			618,256			(57,350)	(462,490)	(8)
Beginning balance, common shares (in shares) at Jun. 30, 2024				246,774,184
Beginning balance at Jun. 30, 2024	102,756			$ 25			610,395			(57,350)	(450,314)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(12,176)										(12,176)
Foreign currency translation	(8)											(8)
Equity-based compensation expense	5,168						5,168
Issuance of common shares as consideration for the acquisition of Pangiam (in shares)				2,144,073
Issuance of common shares as consideration for the acquisition of Pangiam	2,987						2,987
Issuance of shares for equity-based compensation awards, net (in shares)				1,142,670
Issuance of shares for equity-based compensation awards, net	$ (294)						(294)
Ending balance, common shares (in shares) at Sep. 30, 2024	250,060,927			250,060,927
Ending balance at Sep. 30, 2024	$ 98,433			$ 25			$ 618,256			$ (57,350)	$ (462,490)	$ (8)